Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Santhera's Phase III program with Catena®/Raxone® in Duchenne muscular dystrophy on track to deliver pivotal data early in 2Q 2014
RTL therapy for multiple sclerosis: a Phase I clinical study.
Breastfeeding and multiple sclerosis.
Translating Fatigue to Human Performance.
Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis.
Alemtuzumab benefits hard-to-treat MS patients
Rituximab versus fingolimod after natalizumab in multiple sclerosis patients.
Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study.
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse-Remitting Multiple Sclerosis
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed.
Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
Rituximab product approval information - Licensing action
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial.
Copolymer-1 promotes neurogenesis and improves functional recovery after acute ischemic stroke in rats.
Determination and characterization of a cannabinoid receptor in rat brain.
Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.
Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.
Launch of a phase 3 clinical trial in the treatment of Alzheimer’s disease with masitinib
Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease.
Inflammation-induced fatigue: Exploring neurobiological mechanisms and potential treatments
Forward Pharma Receives Decision to Grant From EPO for DMF Patent in Europe
Novantrone (mitoxantrone HCl) Injection February 2009
Acute transverse myelitis: demyelinating, inflammatory, and infectious myelopathies.
Mitoxantrone and ametantrone induce interstrand cross-links in DNA of tumour cells.
Receptos to Deliver Scientific Presentations Regarding RPC1063 at the 2014 American Academy of Neurology (AAN) Annual Meeting

Pages